1. Human plasma‐derived alpha1‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study. Issue 2 (13th December 2020) Authors: Lagarde, William H.; Courtney, Kecia L.; Reiner, Barry; Steinmann, Kimberly; Tsalikian, Eva; Willi, Steven M. Journal: Pediatric diabetes Issue: Volume 22:Issue 2(2021) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗